We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > CK0802

News List

Cellenkos Announces FDA Clearance for Trial of CK0802 for COVID-19 ARDS americanpharmaceuticalreview
June 08, 2020
Cellenkos announced the US Food & Drug Administration (FDA) has cleared the way to initiate a Phase 1 clinical trial of CK0802 (Cryopreserved Cord Blood Derived T-Regulatory Cells) for treatment of COVID-19 associated acute respiratory distress syndrome.
Cellenkos Focuses on the Development of Cell-Therapy for CoV-ARDS americanpharmaceuticalreview
March 20, 2020
Cellenkos has submitted a clinical development proposal to the Biomedical Advanced Research and Development Authority (BARDA) to start a Phase 1/2 clinical trial ...
Cellenkos to trial cell therapy for CoV-ARDS pharmaceutical-technology
March 19, 2020
Cellenkos has filed a proposal with the Biomedical Advanced Research and Development Authority (BARDA) to conduct a Phase I / II clinical trial of CK0802 to treat Covid-19 ...